Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Apr 1, 2019 · 10-K · 91 days after period end · 0001654954-19-003861
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $95.49K |
| Net Income | -$18.74M | -$16.34M | -$47.48M | -$2.61M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Apr 1, 2019 · 91 d after period end
